Bank of New Hampshire Reduces Stock Position in SPDR S&P Biotech ETF (NYSEARCA:XBI)

Bank of New Hampshire trimmed its holdings in shares of SPDR S&P Biotech ETF (NYSEARCA:XBI) by 39.6% during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 335 shares of the exchange traded fund’s stock after selling 220 shares during the quarter. Bank of New Hampshire’s holdings in SPDR S&P Biotech ETF were worth $33,000 at the end of the most recent reporting period.

Several other hedge funds have also recently made changes to their positions in the business. Scarborough Advisors LLC bought a new stake in SPDR S&P Biotech ETF during the fourth quarter worth approximately $32,000. ORG Partners LLC bought a new position in shares of SPDR S&P Biotech ETF during the 2nd quarter valued at approximately $40,000. Vima LLC bought a new position in shares of SPDR S&P Biotech ETF during the 4th quarter valued at approximately $45,000. Resources Management Corp CT ADV raised its holdings in SPDR S&P Biotech ETF by 30.3% during the 2nd quarter. Resources Management Corp CT ADV now owns 593 shares of the exchange traded fund’s stock valued at $55,000 after buying an additional 138 shares during the period. Finally, SOA Wealth Advisors LLC. lifted its position in SPDR S&P Biotech ETF by 79.8% in the first quarter. SOA Wealth Advisors LLC. now owns 597 shares of the exchange traded fund’s stock worth $57,000 after buying an additional 265 shares during the last quarter.

SPDR S&P Biotech ETF Stock Down 1.2 %

NYSEARCA XBI opened at $96.33 on Tuesday. The firm has a market capitalization of $7.34 billion, a price-to-earnings ratio of 11.47 and a beta of 1.11. SPDR S&P Biotech ETF has a 52 week low of $63.80 and a 52 week high of $103.52. The company has a fifty day moving average of $98.64 and a two-hundred day moving average of $94.07.

SPDR S&P Biotech ETF Company Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.